Skip to main navigation Skip to search Skip to main content

Structural mechanism for tyrosine hydroxylase inhibition by dopamine and reactivation by Ser40 phosphorylation

  • María Teresa Bueno-Carrasco
  • , Jorge Cuéllar*
  • , Marte I Flydal
  • , César Santiago
  • , Trond-André Kråkenes
  • , Rune Kleppe
  • , José R López-Blanco
  • , Miguel Marcilla
  • , Knut Teigen
  • , Sara Alvira-De-Celis
  • , Pablo Chacón
  • , Aurora Martinez*
  • , José M Valpuesta*
  • *Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

89 Citations (Scopus)
145 Downloads (Pure)

Abstract

Tyrosine hydroxylase (TH) catalyzes the rate-limiting step in the biosynthesis of dopamine (DA) and other catecholamines, and its dysfunction leads to DA deficiency and parkinsonisms. Inhibition by catecholamines and reactivation by S40 phosphorylation are key regulatory mechanisms of TH activity and conformational stability. We used Cryo-EM to determine the structures of full-length human TH without and with DA, and the structure of S40 phosphorylated TH, complemented with biophysical and biochemical characterizations and molecular dynamics simulations. TH presents a tetrameric structure with dimerized regulatory domains that are separated 15 Å from the catalytic domains. Upon DA binding, a 20-residue α-helix in the flexible N-terminal tail of the regulatory domain is fixed in the active site, blocking it, while S40-phosphorylation forces its egress. The structures reveal the molecular basis of the inhibitory and stabilizing effects of DA and its counteraction by S40-phosphorylation, key regulatory mechanisms for homeostasis of DA and TH.

Original languageEnglish
Article number74
Number of pages17
JournalNature Communications
Volume13
Issue number1
DOIs
Publication statusPublished - 10 Jan 2022

Bibliographical note

Funding Information:
This research was supported by the grant PID2019-105872GB-I00/AEI/10.13039/ 501100011033 from the Spanish Ministry of Science and Innovation to J.M.V. and J.C. as well as FRIMEDBIO (261826) from the Research Council of Norway to A.M.; the Western Norway Regional Health Authorities (912246 to A.M. and 912264 to R.K.), the K.G.

Publisher Copyright:
© 2022, The Author(s).

Fingerprint

Dive into the research topics of 'Structural mechanism for tyrosine hydroxylase inhibition by dopamine and reactivation by Ser40 phosphorylation'. Together they form a unique fingerprint.

Cite this